Daniel Li

Daniel Li is an accomplished professional in clinical operations with extensive experience in oncology and related therapeutic areas. Currently serving as the Global Head of Clinical Site Partnerships at Gilead Sciences since March 2014, Daniel leads a global team to enhance relationships with investigator sites and optimize clinical trial delivery. Past roles include heading the Lung/GI Clinical Operations Team and serving as Regional Head of APAC Clinical Operations, managing trials across various therapeutic areas in multiple countries. Prior experience includes positions as Associate Director at PAREXEL and Clinical Research Associate at MSD and PPD, where Daniel monitored diabetes and oncology trials. Daniel holds a Bachelor of Science in Human Biology and Statistics from the University of Toronto.